How new weight loss drugs will impact insurance premiums – Marketplace
The FDA has approved a new weight-loss drug, Eli Lillys Zepbound, sold under the name Mounjaro when it was only a diabetes drug. This is a new competitor to competitor Novo Nordisk’s very popular Wegovy injectable. Although these drugs can quickly help people lose weight, it is not yet clear how much they will increase …